Engineered bacteria are emerging as powerful tools for carbon fixation, offering an alternative to costly mechanical CO₂ capture. Synthetic biology enables the design of artificial metabolic pathways, transforming greenhouse gases into valuable products and bringing us closer to industrial-scale climate solutions. This article explores the science, applications, safety, and challenges of using modified microorganisms for a carbon-neutral future.
Carbon fixation by bacteria is emerging as one of the most promising directions in climate technology, as global warming forces scientists to seek radical ways to reduce greenhouse gas concentrations. Instead of building expensive and energy-intensive physical-chemical CO₂ capture systems, researchers propose using living microfactories-bacteria programmed by bioengineering methods to convert CO₂ into organic compounds.
To grasp the essence of the bioengineering revolution, it's important to understand which bacteria naturally absorb carbon dioxide. Photoautotrophic microorganisms, such as cyanobacteria, use the classical Calvin cycle for this purpose, where the key enzyme is RuBisCO-responsible for binding inorganic carbon molecules.
However, this natural mechanism has a critical flaw: RuBisCO operates very slowly and is prone to mistakes, often confusing carbon dioxide with oxygen. At high O₂ concentrations, a process called photorespiration is triggered, wasting the cell's energy and reducing overall carbon assimilation efficiency by nearly a quarter.
Nature developed its metabolic mechanisms billions of years ago, under atmospheric conditions radically different from today's. Evolution optimized cells for survival during nutrient scarcity, not for the rapid removal of excess anthropogenic emissions.
The natural rate of carbon assimilation by microorganisms cannot keep up with modern industrial emissions. Biologists have concluded that simply selecting better-performing strains will not solve the climate problem-ecosystems require large-scale technological intervention.
Modern synthetic biology moves away from copying inefficient natural mechanisms. Instead, scientists design entirely artificial metabolic pathways that have never existed in the living world. Using computer modeling, bioengineers combine enzymes from different organisms-plants, animals, and extremophilic bacteria.
Cutting-edge computational algorithms help assemble optimal gene chains by simulating millions of possible biochemical reactions. To explore more about this automation, see the article Artificial Intelligence and Synthetic Biology: How Machines Are Creating New Forms of Life.
A breakthrough example is the CETCH cycle, developed by biochemists. It comprises more than a dozen enzymes sourced from multiple kingdoms of life and operates completely independently of the Calvin cycle. This new reaction chain doesn't rely on RuBisCO and avoids erroneous reactions with oxygen.
Artificial carbon fixation cycles display kinetic efficiency far exceeding their natural counterparts, requiring far less ATP energy to fix a single $CO_2$ molecule. This paves the way for creating super-strains of bacteria capable of absorbing greenhouse gases at unprecedented rates.
Translating theoretical computer models into living cells requires surgical precision. Modern metabolic engineering relies on CRISPR-Cas technology and large-scale de novo DNA assembly methods. Bioengineers literally rewrite bacterial chromosomes, removing entire genome sections that cause wasteful, energy-intensive processes.
Large-block programming has replaced point mutations: scientists synthesize long nucleotide chains encoding the entire artificial metabolic pathway and insert them into bacterial chassis. This allows a complete overhaul of the cell's internal logic, transforming it into a specialized bioreactor.
The main challenge is that cells perceive foreign genes as evolutionary noise or threats. New enzymes may conflict with native bacterial metabolites, causing toxic shock or energy depletion. The organism strives to disable or eject artificially imposed DNA segments.
To overcome this resistance, engineers use dynamic regulatory circuits: molecular "switches" that activate carbon fixation only when the cell has accumulated enough biomass. This approach eases the strain on cell survival and stabilizes biosynthesis.
To scale these technologies, closed photobioreactors and fermenters are built, optimized for modified strains. Industrial flue gases rich in $CO_2$ are continuously supplied to these systems. Bacteria capture carbon directly from factory emissions, preventing its release into the atmosphere.
These biological complexes offer distinct advantages over bulky mechanical chemical absorption systems. For an overview of current approaches, see Carbon Traps Explained: How CO₂ Capture Technologies Fight Climate Change. The biological method requires less infrastructure and produces no toxic chemical waste.
The main advantage of programmable microorganisms is their ability not only to capture carbon, but also to transform it into valuable products. During gas fixation, bacteria can synthesize bioplastics (such as polyhydroxyalkanoates), alcohols, organic acids, and components for aviation biofuel.
In effect, carbon capture plants become carbon-negative chemical facilities. Greenhouse gas that once damaged the climate becomes a free feedstock for the circular economy, making biotechnological fixation attractive to large-scale industry.
Synthetic biology offers enormous potential, but working with artificially modified organisms requires strict control. Should super-bacteria escape industrial bioreactors, they could unpredictably affect wild ecosystems-outcompeting natural microbes or passing on synthetic genes.
To prevent biological accidents, scientists embed "kill-switch" mechanisms in bacterial DNA. These living factories are designed to survive only in the presence of specific artificial amino acids available exclusively inside laboratory circuits-should they enter the wild, the cells quickly die due to their inability to synthesize vital proteins.
Beyond safety, metabolic engineering faces a serious economic hurdle. Building and maintaining large-scale photobioreactors requires substantial initial investment. Gas purification and maintaining optimal temperatures for bacterial life consume resources, which can temporarily reduce the overall environmental benefit.
The technology will only become widespread when the cost of bioplastic or synthetic fuel drops below that of petrochemical analogues. Today, the sector is transitioning from venture-backed scientific startups to pilot industrial plants, facing rigorous market scrutiny.
The creation of artificial metabolic pathways shifts climate technology from passive containment to active management. Modified microorganisms can not only halt greenhouse gas accumulation but also form the backbone of a new, eco-friendly chemical industry.
The success of this technological paradigm depends on balancing strict biosafety protocols with the willingness of major industries to invest in biotechnological platforms. Integrating programmable biology into the real economy will be a key step toward achieving planetary carbon neutrality.